• ProTip SAS Closes USD 4.7 (EUR 3.8) Million Financing Round More...

• Ferring Pharmaceuticals Donates $10 Million to the Salk Institute for Biological Studies More...

• Biotech All Stars Buy Castoff Experimental Merck & Co., Inc. (MRK) Cancer Drug More...

• Foundation Medicine, Novartis AG (NVS) Ink Pact to Provide Genomic Information for Clinical Oncology Programs More...

• Eli Lilly and Company (LLY) CEO: No Mega Pharma Deals for Us More...

• Zogenix, Inc. and Mallinckrodt Inc., a Covidien plc (COV) Company, Enter Exclusive Co-Promotion Agreement for SUMAVEL(R) DosePro(R) More...

• Reinnervate Limited and Tecan to Develop Automated 3D Cell Culture Solutions for Improved Cellular Assays More...

• Healthpoint Biotherapeutics Signs Brazilian Distribution Agreement For OASIS® Extracellular Matrix Product Line More...

• Achillion Pharmaceuticals, Inc. (ACHN) Announces Resignation of Chief Medical Officer More...

• KaloBios Pharmaceuticals, Inc. Appoints Néstor Molfino as Chief Medical Officer More...

• ChemoCentryx, Inc. Announces Appointment of James L. Tyree to the Company's Board of Directors More...

• IntelliCell BioSciences (SVFC) Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board More...

• Ohr Pharmaceutical (OHRP) Announces Additions to Ophthalmic Scientific Advisory Board More...

• Supernus Pharmaceuticals Reports First Quarter 2012 Financial Results More...

• Feds Seize Global Biotechnologies' Misbranded Drugs More...

• PerkinElmer, Inc. (PKI) to Create New Personalized Health Innovation Center of Excellence in Massachusetts More...

• FEI Company Announces Plans for Facility Expansion in the Czech Republic More...

• Novartis AG (NVS) Recalls Mispackaged Birth Control Pills More...

• GlaxoSmithKline (GSK) and XenoPort, Inc. (XNPT) Receive FDA Approval for Horizant® for Postherpetic Neuralgia More...

• Otsuka Pharmaceutical Co., Ltd.'s Experimental TB Drug Fights Resistant Disease More...

• Curis, Inc. (CRIS) Announces Publication of Erivedge™ Data in The New England Journal of Medicine More...

• Biovest International, Inc. Release: National Cancer Institute Study Demonstrates Significant Overall Survival and Time-to-Next-Treatment Benefits for BiovaxID® Cancer Vaccine Following Rituximab-Chemotherapy in Mantle Cell Lymphoma Study More...

• Argos Therapeutics, Inc. Presents Positive Phase 1a Data for AGS-009 in Patients With Lupus at 2012 EULAR Congress More...

• OXiGENE (OXGN) Announces Publication of Key Data Showing Antitumor Activity of ZYBRESTAT® Combined With Bevacizumab More...

• Pregnancy Complications Not Cut By Omega-3s, University of Adelaide Study More...

• University of Rochester Medical Center Study Links PTSD to Hidden Head Injuries Suffered in Combat More...

• Stress May Delay Brain Development in Early Years, University of Wisconsin-Madison Study More...

• Genocea Biosciences Announces New Research Identifying Potential Vaccine Candidates for Chlamydia More...

• UCB, Inc. (UCBJF.PK) Release: RAPID™-PsA Study Showed That Certolizumab Pegol Improved the Signs and Symptoms of Psoriatic Arthritis More...

• Bionor Pharma ASA Release: International Patent Application Submitted Covering Vaccines for Influenza (Universal Vaccine), Hepatitis C, Cytomegalovirus and Human Papillomavirus More...

• Bionor Pharma ASA Release: International Patent Application Submitted for the Therapeutic and Potentially Preventive Vaccine Vacc-HIV, CombiningBionor's Vacc-4x and Vacc-C5 More...

• Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property More...

• Innophos Holdings, Inc. Set to Launch Cal-Rise® in Canada for Low Sodium Baking More...